Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot, Ségolène Brichler, Richard Layese, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1046-1062
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 865
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
The changing context of hepatitis D
Mario Rizzetto, Saeed Hamid, F. Negro
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 126
Hepatitis D Virus Infection
Tarik Asselah, Mario Rizzetto
New England Journal of Medicine (2023) Vol. 389, Iss. 1, pp. 58-70
Closed Access | Times Cited: 52
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
Zeitschrift für Gastroenterologie (2021) Vol. 59, Iss. 07, pp. 691-776
Open Access | Times Cited: 73
Interferon‐based treatment of chronic hepatitis D
Lisa Sandmann, Heiner Wedemeyer
Liver International (2022) Vol. 43, Iss. S1, pp. 69-79
Open Access | Times Cited: 43
Hepatitis D
Francesco Negro, Anna S. Lok
JAMA (2023) Vol. 330, Iss. 24, pp. 2376-2376
Closed Access | Times Cited: 40
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Homie Razavi, Marı́a Buti, Norah A. Terrault, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 576-580
Open Access | Times Cited: 36
Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis
Robert G. Gish, Robert J. Wong, Gian Luca Di Tanna, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1129-1140
Open Access | Times Cited: 23
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 9
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
Victor de Lédinghen, Claire Fougerou‐Leurent, Estelle Le Pabic, et al.
JHEP Reports (2024) Vol. 6, Iss. 8, pp. 101057-101057
Open Access | Times Cited: 8
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis
Elisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1
Hepatitis D Virus and Hepatocellular Carcinoma
Patrizia Farci, Grazia Anna Niro, Fausto Zamboni, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 830-830
Open Access | Times Cited: 43
Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
Toni Herta, Magdalena Hahn, Melanie Maier, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 517-517
Open Access | Times Cited: 28
HDV RNA assays: Performance characteristics, clinical utility, and challenges
Heiner Wedemeyer, Mitchell Leus, Thomas R. Battersby, et al.
Hepatology (2023)
Open Access | Times Cited: 18
Hepatitis delta testing trends in a US national cohort: An analysis of patient and provider-level predictive factors
Binu V. John, Mahmoud Manouchehri Amoli, Donna M. Evon, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 6
HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
Caterina Sagnelli, Evangelista Sagnelli, Antonio Russo, et al.
Life (2021) Vol. 11, Iss. 2, pp. 169-169
Open Access | Times Cited: 37
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life
Tarik Asselah, Dimitri Loureiro, Frédéric Le Gal, et al.
Liver International (2021) Vol. 41, Iss. 7, pp. 1509-1517
Closed Access | Times Cited: 37
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
A. Wranke, Benjamin Heidrich, Katja Deterding, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1359-1367
Open Access | Times Cited: 15
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis
Mathias Jachs, Teresa Binter, Caroline Schmidbauer, et al.
United European Gastroenterology Journal (2021) Vol. 9, Iss. 10, pp. 1119-1127
Open Access | Times Cited: 27
Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy
Yu‐Shan Huang, Hsin‐Yun Sun, Shu‐Yuan Ho, et al.
Clinical Infectious Diseases (2025)
Open Access
Severe Liver‐Related Outcomes in Patients With Hepatitis Delta: Results From a Multi‐Ethnic Multicenter Long‐Term Follow‐Up Study
Arno Furquim d’Almeida, Erwin Ho, Liesbeth Govaerts, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 2, pp. 1-15
Open Access
Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co‐Infection in Senegal
Bruce Shinga Wembulua, Frédéric Le Gal, Ousseynou Ndiaye, et al.
Liver International (2025) Vol. 45, Iss. 3
Open Access
Screening for hepatitis B, C and D in metropolitan France from 2016 to 2022: A map based on the National Health Data System with a focus on HDV screening
Céline Rigaud, Sandrine François, Paul Carrier, et al.
(2025)
Closed Access
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock‐Jacobs, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100461-100461
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top